ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
Business

Fujifilm consolidates Chinese ultrasound business

The FC1 combines Fujifilm and SonoSite technologies.

TOKYO -- Fujifilm has merged its ultrasound diagnostic equipment operations in China, transferring employees from a subsidiary to its main Chinese unit to bolster its medical device business.

     In 2012, the Japanese company acquired SonoSite, a U.S. medical equipment maker whose specialties include ultrasound equipment used in anesthesia, emergency care, orthopedics and other treatments.

     North America and Latin America account for roughly half its sales, while Asia and Oceania make up only about one-fourth -- an area where its parent sees room to grow.

     To this end, Fujifilm recently moved several dozen SonoSite employees to its Chinese unit. It plans to strengthen its tie-up with SonoSite in the U.S. and Japan as well.

     China's ultrasound diagnostic equipment market is seen growing from about $900 million in 2012 to $1.5 billion within five years, according to U.S. research company IHS.

     Fujifilm aims to boost sales there through such steps as marketing SonoSite products to hospitals and clinics that already use its own offerings. The Tokyo-based company, which has four sales and service offices in China, plans to make use of its name recognition in the medical device business.

     The Fujifilm FC1 will be released next month. The unit, which combines new image processing technology by Fujifilm with SonoSite's miniaturization technology, has a high-resolution display while being light enough to carry in one hand. It will allow for easier discovery of such problems as clots of cholesterol that can cause strokes.

(Nikkei)

 

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more